Spermatogenesis is a highly organized process to ultimately produce mature sperm sustainably throughout life. In the mouse, spermatogenesis occurs soon after birth when mitotically inactive differentiating germ cells, termed gonocytes \[[@r1], [@r2]\] or prospermatogonia \[[@r3]\], give rise to spermatogonia to initiate proliferation. Within the spermatogonial cell population, a small fraction of undifferentiated, unipotential spermatogonia, i.e., spermatogonial stem cells, self-renew to maintain their population \[[@r4], [@r5]\]. In addition, a subset of spermatogonial progenitor cells differentiate into meiotic spermatocytes followed by haploid spermatids \[[@r6]\] . This complex process of spermatogenesis is strictly regulated via various molecular mechanisms to orchestrate and maintain homeostasis during spermatogenesis.

Alternative splicing (AS), a mechanism to produce multiple gene products from a single gene locus, plays an important role in transcriptome and proteome complexity and facilitates proper tissue development \[[@r7], [@r8]\]. In humans, more than 90% of genes have splicing isoforms \[[@r9], [@r10]\]. The contribution of AS in cell lineage specification and differentiation is well investigated in neural development, especially brain formation \[[@r11],[@r12],[@r13]\]. Recently, high-throughput analysis of microarrays \[[@r14]\] and RNA sequencing \[[@r15],[@r16],[@r17]\] detected numerous gene isoforms resulting from AS within spermatogenic cell types in the testis, with numbers second only to the brain. Despite the high levels of AS that occur in the testis, the functional importance of AS for spermatogenesis is not well understood.

RNA-binding proteins (RBPs) play a central role in AS regulation by interacting with nascent transcripts to alter their mature isoforms via common forms of AS such as exon retention or skipping, 5′ or 3′ alternative exon, or mutually exclusive exon \[[@r12], [@r18]\]. The polypyrimidine tract-binding protein (PTBP) family includes highly conserved RBPs from *Caenorhabditis elegans* to mammals. They regulate AS, mainly via exon skipping \[[@r19]\], by binding to the polypyrimidine-rich intronic region of nascent RNA. Previous studies showed that genetic mutation in *Drosophila* PTBP (dmPTB or hephaestus), a male germline--specific mRNA isoform, causes infertility and a deficiency in spermatid individualization \[[@r20], [@r21]\].

In mice, three orthologous genes coding PTBPs are known: *Ptbp1*, *Ptbp2* (also known as *nPtb*), and *Ptbp3* (also known as *Rod1*). According to the public FANTOM5 mouse promoterome database (<http://fantom.gsc.riken.jp/zenbu/>), expression of *Ptbp3* is high in embryonic stem cells and hematopoietic lineage cells but less evident in cells of the adult testis. By contrast, *Ptbp2* is highly expressed by neurons and testis \[[@r22]\]. Recent studies using a mouse knockout (KO) model showed that germ cell--specific loss of function of *Ptbp2* causes a severe abnormality in spermatogenesis, i.e., spermatid elongation was severely compromised in the conditional KO (cKO) model \[[@r23], [@r24]\], suggesting the necessary role of PTBPs in spermatogenesis via genes that are highly conserved.

*Ptbp1*, the focal gene of this study, regulates differentiation of many types of cells in mice including cardiomyocytes \[[@r25]\], neural cells \[[@r11], [@r26]\], and B lymphocytes \[[@r27]\]. PTBP1 seems to be widely expressed in various tissues, including testis (see FANTOM5 mouse promoterome database). However, our previous study \[[@r28]\] and another \[[@r29]\] reported that conventional *Ptbp1* KO mice showed a complete embryonic lethal phenotype soon after implantation; thus the role(s) of PTBP1 in spermatogenesis is still unclear.

Here, we investigated the role(s) of PTBP1 in spermatogenesis in mice by using a germ cell--specific gene KO model for escaping the embryonic lethal phenotype observed in the conventional KO model. Although sperm counts in the *Ptbp1* cKO mice were comparable to those in control mice at 2 months old, significantly more seminiferous tubules showed degeneration in spermatogenic function in the *Ptbp1* cKO mice at that age. We also observed that early neonatal proliferation of spermatogonia was significantly retarded in the *Ptbp1* cKO mice. Furthermore, hydroxytamoxifen-induced deletion of PTBP1 from cultured spermatogonia caused severe proliferation arrest accompanied by an increase in apoptotic cell death. These findings suggest that PTBP1 contributed to proper spermatogenesis through regulation of cell proliferation.

Materials and Methods {#s1}
=====================

Animals and ethics
------------------

C57BL/6J mice were purchased from Japan SLC (Shizuoka, Japan). *Ptbp1^flox/flox^* mice were established in our laboratory by a conventional targeting strategy using 129-strain embryonic stem cells as described previously \[[@r26], [@r28]\] and backcrossed at least ten times to C57BL/6J mice. *Ngn3-Cre* transgenic mice \[[@r30]\] were introduced from RIKEN BioResource Research Center (Wakō, Japan) and backcrossed at least eight times to C57BL/6J mice. *Gt(ROSA)26^Sortm4(ACTB-tdTomato,-EGFP)Luo^* (*mTmG*) mice were purchased from The Jackson Laboratory (Bar Harber, ME, USA). *CAG-CreMER* mice were developed in our laboratory \[[@r31]\]. Mice were maintained under pathogen-free conditions in the experimental animal facility at the Institute of Medical Science, the University of Tokyo (Tokyo, Japan). All research protocols were conducted under guidelines approved by the Institutional Animal Care and Use Committee of the University of Tokyo (approval no. PA10-59).

Immunohistochemistry and measurement of seminiferous tubule area
----------------------------------------------------------------

Mice were euthanized, and then their testes were dissected. The testes were fixed with phosphate-buffered saline (PBS) containing 4% (w/v) paraformaldehyde (Nacalai Tesque, Kyoto, Japan) at 4°C overnight with gentle shaking. After fixation, testes were dehydrated in a graded ascending series of ethanol (25--100%, v/v), embedded in paraffin, and sectioned at a thickness of 5 μm. Sections were deparaffinized in Lemosol A (FUJIFILM Wako Pure Chemical, Osaka, Japan) and rehydrated by serial incubations in ethanol (100% to 70%, v/v) followed by washing in deionized, distilled water twice. For antigen retrieval, rehydrated sections were heated in sodium citrate buffer \[10 mM sodium citrate containing 0.05% (v/v) Tween 20, pH 6.0\] or EDTA buffer \[10 mM Tris, 1 mM EDTA containing 0.05% (v/v) Tween 20, pH 9.0\] for 20 min at 120°C in an autoclave. Sections were then permeabilized with 0.3% (v/v) or 0.025% Triton X diluted in PBS or Tris-buffered saline (TBS), respectively and blocked using bovine serum albumin (Nacalai Tesque) at room temperature for 1 h. Slides were incubated with primary antibodies diluted in SignalStain antibody diluent (Cell Signaling Technology, Danvers, MA, USA) at 4°C overnight with gentle shaking. Then, sections were incubated with Alexa Fluor 488--, 555--, or 647--conjugated host species--specific secondary antibodies (all from Thermo Fisher Scientific, Tokyo, Japan) for 1 h at room temperature in the dark. After the antibody treatment, sections were incubated with 0.1% (w/v) Sudan black B (Sigma-Aldrich, St. Louis, MO, USA) solution for quenching autofluorescent signals \[[@r32], [@r33]\]. The nucleus was counterstained with 4,6-diamidino-2-phenylindole and mounted with a coverslip with anti-fade mountant solution (PermaFluor Aqueous Mounting Medium or ProLong Glass, Thermo Fisher). Fluorescent signals were detected using a fluorescent microscope (BZ-9000 or BZ-X700, Keyence, Osaka, Japan). The primary antibodies used were as follows: rabbit anti-PLZF (sc-22839, Santa Cruz Biotechnology Inc., Dallas, TX, USA), goat anti-PTBP1 (sc-16547, Santa Cruz Biotechnology), rabbit anti-WT1 (sc-192, Santa Cruz Biotechnology), rabbit anti-MVH (ab13840, Abcam, Cambridge, MA, USA), rat anti-germ cell--specific nuclear antigen (clone TRA98, BioAcademia, Osaka, Japan), rabbit anti-cleaved caspase-3 (CC3) antibody (9664, Cell Signaling Technology), rat anti-haploid sperm cell--specific antigen (clone TRA54, ab92286, Abcam), goat anti-SCP3 (sc-20845, Santa Cruz Biotechnology), and goat anti-GATA4 (sc-1237, Santa Cruz Biotechnology). For measurement of area of seminiferous tubules, tubules of which major axis length was less than 2-fold of minor axis were selected, and area was analyzed using ImageJ software (<https://imagej.nih.gov/ij/>).

Hematoxylin and eosin (HE) staining
-----------------------------------

Testes were fixed with Bouin's solution (FUJIFILM Wako Pure Chemical) at 4°C overnight with gentle shaking. Fixed testes were washed in PBS and then dehydrated by serial incubations in ethanol (70--100%, v/v). Dehydrated testes were embedded in paraffin, sectioned, or rehydrated as described under Immunohistochemistry. For histological analysis, sections were stained with hematoxylin and eosin (HE) by a standard HE staining procedure. Stained sections were dehydrated by serial incubations in ethanol (50--100%, v/v) followed by permeation by incubation twice in Lemosol A (FUJIFILM Wako Pure Chemical). Sections were mounted with a coverslip with Mount-Quick (Daido Sangyo, Saitama, Japan) and observed under a fluorescence microscope (BZ-9000, Keyence).

Germline stem (GS) cell development
-----------------------------------

A mouse having *mTmG; CAG-CreMER; Ptbp1^flox/flox^* (*Ptbp1-FF*) or *mTmG; CAG-CreMER; Ptbp1^flox/wt^* (*Ptbp1-FW*) was used for germline stem (GS) cell development. Testes of 7--10-day-old postpartum neonates were collected and digested into single cells enzymatically as described previously \[[@r34]\]. Single cells were washed twice with PBS containing 2 mM EDTA and 0.5% (w/v) bovine serum albumin. THY1.2-positive cells, the fraction in which undifferentiated spermatogonia are highly enriched \[[@r35], [@r36]\], were sorted by magnetic-activated cell sorting technology (CD90.2 MicroBeads, Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer's instructions. The isolated cell fraction was seeded onto mitotically inactivated feeder cells (X-ray--irradiated or Mitomycin C--treated mouse embryonic fibroblasts) to develop into stably self-renewing GS cells. GS cells were cultured as described previously \[[@r37]\] at 37°C in a humid atmosphere of 5% CO~2~ and 95% air. GS cells were passaged every 7 to 10 days at a density of 1--2 × 10^5^ cells/ml. For initiation of tamoxifen-induced recombination of the *flox* allele, 1 μM 4-hydroxytamoxifen (4OHT; LKT Laboratories, St. Paul, MN, USA) was added to the culture medium.

RNA extraction, cDNA synthesis, and quantitative polymerase chain reaction (qPCR)
---------------------------------------------------------------------------------

Total RNA from mouse tissues, except brain, was extracted using Sepasol-RNA I Super G solution (Nacalai Tesque) according to the manufacturer's instructions and then treated with DNase I (Takara, Shiga, Japan) to digest potentially contaminating genomic DNA. For extracting RNA from brain, a NucleoSpin RNAII system (Macherey-Nagel, Düren, Germany) was used in which DNase for digestion of contaminated genomic DNA was included. cDNA was reverse transcribed from RNA using a SuperScript VILO cDNA synthesis kit (Thermo Fisher). Synthesized cDNA was used for quantitative polymerase chain reaction (qPCR) in a PCR reaction mixture of THUNDERBIRD SYBR qPCR Mix (Toyobo, Osaka, Japan) using the StepOne system (Thermo Fisher). The fold difference was calculated using the ΔΔC~t~ method \[[@r38]\] with *Gapdh* as the reference. Primer sequences were as follows: for *Ptbp1*, forward GGTCTCTTCCGTGTGCCATG and reverse CTGCGCTCCTGTTGTCACCT, and for *Gapdh*, forward ATGAATACGGCTACAGCAACAGG and reverse CTCTTGCTCAGTGTCCTTGCTG.

Flow cytometry
--------------

Flow cytometry was used to detect intracellular proteins or to analyze phases of cell cycle. For protein detection, cells were fixed with 1% (v/v) paraformaldehyde prepared in PBS for 10 min at room temperature and then permeabilized using 90% (v/v) ice-cold methanol for 30 min. Permeabilized cells were incubated with rabbit anti-CC3 antibody (9664, Cell Signaling Technology) or goat anti-PTBP1 (sc-16547, Santa Cruz Biotechnology) at 4°C for 1 h and then exposed to Alexa Fluor 647--conjugated host species--specific secondary antibodies (Thermo Fisher). For cell cycle analysis, cells were fixed and permeabilized in ethanol (90% (v/v) prepared in PBS) overnight at --20°C. Thereafter, DNA was stained with propidium iodide (50 µg/ml, Sigma-Aldrich) and endogenous RNA was simultaneously digested with RNase A (200 µg/ml, Merck Millipore) for 20 min at 37°C. Stained cells were analyzed using a FACSCalibur or FACSVerse flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA). Data were analyzed using FlowJo software (FlowJo, LLC; <https://www.flowjo.com>).

Statistical analysis
--------------------

All experiments were replicated at least three times. The data are presented as means ± standard error of the mean. Differences between genotypes or ages were tested using Student's *t*-test except GS cell proliferation assay. Differences of GS cell proliferation were tested by one- way ANOVA followed by Tukey\'s multiple comparison tests. P values less than 0.05 were considered significant.

Results {#s2}
=======

PTBP1 is highly expressed by spermatogonia and spermatocyte in testicular germ cells
------------------------------------------------------------------------------------

To compare expression levels of *Ptbp1* mRNA in various tissues (e.g., brain, liver, lung, heart, bone marrow, kidney, and testis), these tissues were collected and used for qPCR analysis. All of the tissues analyzed expressed *Ptbp1*, but the level was the highest in testis ([Fig. 1A](#fig_001){ref-type="fig"}Fig. 1.PTBP1 is highly expressed by spermatogonia and spermatocytes in testicular germ cells. (A) Quantitative polymerase chain reaction of *Ptbp1* expression in various tissues. Gene expression was standardized using *Gapdh*, and the expression level of the brain was designated as 1-fold \[n = 3 in each tissue, except testis (n = 2)\]. (B and C) Immunohistochemical analysis of PTBP1 expression in the wild-type adult testis. Sections were stained with (B) anti-PLZF (a marker of spermatogonia, arrowhead) or (C) anti-WT1 (a marker of Sertoli cells, arrowhead) as well as with anti-PTBP1. Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI). Scale bar denotes 50 µm.). The testis consist of germ cells at the various stages of differentiation (i.e., undifferentiated or differentiating spermatogonia, meiotic spermatocytes, round or elongated haploid spermatids) as well as somatic cells such as Sertoli cells and Leydig cells that provide structural and nutritional support for germ cell maintenance and differentiation. PTBP1 protein localization in the testes was determined by immunohistochemistry using adult wild type mice. The expression of PTBP1 was strong in PLZF-positive undifferentiated spermatogonia ([Fig. 1B](#fig_001){ref-type="fig"}) as well as in Wilms tumor gene product (WT1)-positive Sertoli cells ([Fig. 1C](#fig_001){ref-type="fig"}), but it became less evident in cells located on the apical side of seminiferous tubules ([Fig. 1B and 1C](#fig_001){ref-type="fig"}). These results indicated that PTBP1 expression in testicular germ cells is strong in mitotic spermatogonia and becomes weaker after entering meiosis.

Loss of PTBP1 causes an increase in degeneration of seminiferous tubules
------------------------------------------------------------------------

Our previous study \[[@r28]\] and another study \[[@r29]\] revealed that the conventional *Ptbp1* KO mouse exhibits embryonic lethality soon after implantation. To escape this lethal phenotype, we developed a germ cell--specific *Ptbp1* cKO mouse to explore the role of PTBP1 in spermatogenesis. First, we checked the gene KO efficiency of our *Ptbp1* cKO model by immunohistochemistry. The results clearly showed that PTBP1 expression was lost only in MVH-positive germ cells in the *Ptbp1* cKO testis at high efficiency ([Fig. 2A](#fig_002){ref-type="fig"}Fig. 2.Loss of PTBP1 causes an increase in seminiferous tubules showing degeneration of spermatogenesis. (A) Immunohistochemical analysis of PTBP1 expression in control (top) and the *Ptbp1* conditional knockout (cKO) (bottom). Sections were stained with anti-MVH (mouse VASA homolog, a marker of germ cells) and anti-PTBP1. The white arrowhead indicates germ cells expressing PTBP1 in the control mouse, and the yellow arrowhead indicates germ cells without PTBP1 expression in the *Ptbp1* cKO mouse. Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI). Scale bar denotes 50 µm. (B) Fluctuation of the weight of testis during development in *Ptbp1* cKO and control mice. The asterisk depicts a significant difference (\* P \< 0.05, \*\* P \< 0.01; n ≥ 3). (C) Sperm counts from cauda epididymis of a 2- or 6-month-old *Ptbp1* cKO mouse and control. The asterisk depicts a significant difference (P \< 0.05; n ≥ 3). N.S., not significant. (D) Hematoxylin and eosin staining of testis from a 2-month-old *Ptbp1* cKO mouse (bottom) and age-matched control (top). The asterisk depicts seminiferous tubules exhibiting degeneration of spermatogenesis. Scale bar denotes 200 µm., arrowhead). Second, we compared the growth of the testis during postnatal development. Testis weight was comparable between control and cKO mice until 3 weeks of age, but the cKO testis weight was significantly lighter than that of the control at 2 months old (47.9 ± 3.8 and 66.2 ± 5.2 mg, respectively; P \< 0.05) and 6 months old (45.5 ± 4.6 and 83.9 ± 3.8 mg, respectively; P \< 0.01) ([Fig. 2B](#fig_002){ref-type="fig"}). Although sperm counts from the cauda epididymis of 2-month-old mice did not differ significantly between the genotypes, this count was significantly lower in 6-month-old cKO mice than in age-matched controls (0.26 ± 0.10 × 10^7^ and 1.1 ± 0.2 × 10^7^, respectively; \[) ([Fig. 2C](#fig_002){ref-type="fig"}). Finally, we compared the histology of the testis between control and *Ptbp1* cKO mice. HE staining of testes from 2-month-old *Ptbp1* cKO mice exhibited an increase in seminiferous tubules undergoing degeneration of spermatogenesis compared with the control testes ([Fig. 2D](#fig_002){ref-type="fig"}, asterisk). These results suggest that PTBP1 plays an important role(s) in spermatogenesis, although it is not a necessary protein for spermatogenesis.

Loss of PTBP1 reduces proliferation of spermatogonia
----------------------------------------------------

To determine how the loss of PTBP1 causes defects in spermatogenesis, testes were examined using immunohistochemistry methods. During the neonatal period, the number of seminiferous tubules without germ cells gradually decreased in the control, whereas this number remained high in the *Ptbp1* cKO mice ([Fig. 3A](#fig_003){ref-type="fig"}Fig. 3.Loss of *Ptbp1* reduces proliferation of spermatogonia during neonatal period. (A) Immunohistochemical analysis of germ cell distribution in control (top) and a *Ptbp1* conditional knockout (cKO) (bottom) mouse during the neonatal period. Sections were stained with anti-TRA98 (a marker of germ cells) and anti-GATA4 (a marker of the Sertoli cells and Leydig cells). Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI). Scale bar denotes 100 µm. (B) Ratio of tubules without germ cells. The asterisk depicts a significant difference (\*\* P \< 0.01; n ≥ 3). (C) Immunohistochemical analysis of testis sections from neonatal *Ptbp1* cKO and control for TRA98 and cleaved caspase-3 (CC3). Nuclei were stained with DAPI. Scale bar denotes 50 µm. (D) Number of CC3-positive apoptotic cells (P \> 0.05; n ≥ 3). (E) Immunohistochemical analysis of testis sections from neonatal *Ptbp1* cKO and control for PLZF and Ki67. Nuclei were stained with DAPI. Scale bar denotes 50 µm. (F) Ratio of mitotically active spermatogonia (P \> 0.05; n = 3).); the difference was significant at postnatal day 5 ([Fig. 3B](#fig_003){ref-type="fig"}). We also checked progression of first spermatogenesis by immunohistochemistry. The result revealed that ratio of tubules having TRA54-positive haploid spermatid in the *Ptbp1* cKO did not differ compared to the control ([Supplementary Fig. 1](#pdf_001){ref-type="supplementary-material"}: online only), suggesting that progression of spermatogenesis in the *Ptbp1* cKO was, at least until this point, comparable to the control. We next checked whether this retarded expansion of spermatogonia observed in the neonate *Ptbp1* cKO was attributed to an increase of cell death or reduced cell proliferation. Interestingly, neither number of CC3-positive apoptotic cells ([Fig. 3C and 3D](#fig_003){ref-type="fig"}) nor ratio of Ki67-positive cycling cells ([Fig. 3E and 3F](#fig_003){ref-type="fig"}) differed between the control and the *Ptbp1* cKO. Since anti-Ki67 stains cells which enter cell cycle at any phases, these results suggest that retarded expansion of spermatogonia shown in the *Ptbp1* cKO neonate was attributed to prolonged cell cycle and slower proliferation of spermatogonia but not an increase of apoptotic cell death.

Because the difference in sperm number and testis weight between the *Ptbp1* cKO and control mice became more evident in the 6-month-old mice compared with the younger 2-month-old mice, we next analyzed adult testes from 2- and 6-month-old mice by immunohistochemistry methods. The results revealed that seminiferous tubules without PLZF-positive spermatogonia were significantly more abundant in the *Ptbp1* cKO mice than in the control mice, both at 2 and 6 months of age ([Fig. 4A](#fig_004){ref-type="fig"}Fig. 4.Loss of *Ptbp1* reduces proliferation of spermatogonia during adulthood. (A) Immunohistochemical analysis of testis from 2- and 6-month-old *Ptbp1* cKO (bottom) mice and age-matched controls (top). Sections were stained with anti-PLZF (a marker of spermatogonia) and anti-GATA4 (a marker of the Sertoli cells and Leydig cells). Nuclei were stained with DAPI. Scale bar denotes 50 µm. (B) Ratio of tubules without PLZF-positive spermatogonia. The asterisk depicts a significant difference (\*\* P \< 0.01; n = 3). (C) Number of CC3-positive apoptotic cells in the testis from 6-month-old *Ptbp1* cKO mice and age-matched controls (P \> 0.05; n = 3). (D) Area of seminiferous tubules from 2- and 6-month-old *Ptbp1* cKO mice and age-matched controls. The asterisk depicts a significant difference (data were collected from three individual mice in each genotype and age; \*\* P \< 0.01; n = 3)., asterisk), and the ratio tended to become larger (P = 0.059) in the *Ptbp1* cKO mice with age ([Fig. 4B](#fig_004){ref-type="fig"}). On the other hand, number of apoptotic cells in the *Ptbp1* cKO at 6 months of age did not differ compared to the age matched control ([Fig. 4C](#fig_004){ref-type="fig"}). Furthermore, the area of seminiferous tubules, representing the activity level of spermatogenesis \[[@r39],[@r40],[@r41]\], became larger in the 6-month-old testes than in the 2-month-old testes in the control mice, but became smaller in the *Ptbp1* cKO mice with age ([Fig. 4D](#fig_004){ref-type="fig"}). Taken together, these results suggest that PTBP1 assists proliferation of spermatogonia during both neonatal and adult periods.

Induced KO of Ptbp1 from GS cells exhibits severe growth arrest and an increase in apoptotic cell death in vitro
----------------------------------------------------------------------------------------------------------------

Undifferentiated spermatogonia can proliferate on mouse embryonic fibroblasts *in vitro* under stimulation with fibroblast growth factor 2 and glial cell line--derived neurotrophic factor, while retaining spermatogonial characteristics \[[@r34], [@r36], [@r42]\]. To evaluate the role of PTBP1 in spermatogonia *in vitro*, we developed GS cells from a mouse having *mTmG*, *CAG-CreMER*, and *Ptbp1 flox* transgenic loci, in which *Cre*-mediated *loxP* recombination is induced by 4OHT ([Fig. 5A](#fig_005){ref-type="fig"}Fig. 5.*Ptbp1* cKO germline stem (GS) cells exhibit severe growth arrest and an increase in apoptotic cell death *in vitro*. (A) Schematic of allele recombination mediated by the Cre-loxP system. (B) Flow cytometry to analyze tdTomato-positive GS cells in the *Ptbp1-FW* (top) and *Ptbp1-FF* (bottom). 4-Hydroxytamoxifen (4OHT) (induced recombination) or ethanol (placebo) was added to the culture medium. (C) Flow cytometry to analyze PTBP1 expression in *Ptbp1-FW* GS cells and *Ptbp1-FF* GS cells treated with 4OHT or ethanol. (D) Proliferation of *Ptbp1-FW* GS cells and *Ptbp1-FF* GS cells treated with 4OHT or ethanol. Different superscripts depict significant differences within same day (\*\* P \< 0.01; n = 3). (E) Representative morphology of *Ptbp1-FW* GS cells and *Ptbp1-FF* GS cells treated with 4OHT or ethanol. (F) Percentages of cells in G0/G1, S, and G2/M phases. The asterisk depicts a significant difference (\* P \< 0.05, \*\* P \< 0.01; n = 3). (G) Ratio of CC3 positive GS cells. *Ptbp1-FW* GS cells and *Ptbp1-FF* GS cells were treated with 4OHT or ethanol, fixed, stained with an anti-CC3 antibody, and analyzed by flow cytometry. The asterisk depicts a significant difference (\* P \< 0.05, \*\* P \< 0.01; n ≥ 4). *Ptbp1-FW*, *mTmG; CAG-CreMER; Ptbp1^flox/wt^*; *Ptbp1-FF*, *mTmG; CAG-CreMER; Ptbp1^flox/flox^*.). Administration of 4OHT to the culture medium effectively recombined the *mTmG* locus ([Fig. 5B](#fig_005){ref-type="fig"}), and PTBP1 protein clearly disappeared only in the 4OHT-administered *Ptbp1-FF* GS cells ([Fig. 5C](#fig_005){ref-type="fig"}). Using this culture model, we next determined the proliferation activity of GS cells. The results clearly showed that proliferation was severely suppressed in the *Ptbp1-FF* GS cells treated with 4OHT, although 4OHT-administered *Ptbp1-FW* also showed significant reduction of cell proliferation compared to the placebo (ethanol)-administered *Ptbp1-FW or Ptbp1-FF* ([Fig. 5D and 5E](#fig_005){ref-type="fig"}). Next, we checked cell cycle of GS cells by flow cytometry. Ratio of GS cells at G1/G0, S, or G2/M phase did not differ significantly between ethanol- and 4OHT-administered *Ptbp1-FW*, whereas ratio of GS cells at G2/M phase became significantly more, and at G1/G0 phase became significantly less in the 4OHT-administered *Ptbp1-FF* GS cells compared to the ethanol-administered *Ptbp1-FF* GS cells ([Fig. 5F](#fig_005){ref-type="fig"}). In addition, the number of CC3--positive GS cells, which underwent apoptotic cell death, was significantly (P \< 0.05) more in the *Ptbp1-FF* GS cells than in the *Ptbp1-FW* GS cells after 4OHT administration ([Fig. 5G](#fig_005){ref-type="fig"}). These results suggest that PTBP1 contributes to cell cycle regulation and suppresses apoptotic cell death in spermatogonia *in vitro*.

Discussion {#s3}
==========

We investigated the role of PTBP1 during spermatogenesis by using a germ cell--specific gene KO model for escaping its complete lethality in conventional KO mice \[[@r28]\]. Our results demonstrated that loss of PTBP1 from testicular germ cells caused proliferation arrest of early neonatal spermatogonia as well as an increase in seminiferous tubules exhibiting degeneration of spermatogenesis in the postpubertal male. In addition, the cross-sectional area of seminiferous tubules, an indicator of spermatogenesis activity \[[@r39],[@r40],[@r41]\], became larger in the control mice, whereas significantly smaller in the *Ptbp1* cKO mice with age (2 months old *vs*. 6 months old). An *in vitro* GS cell culture model showed that loss of PTBP1 caused severe growth arrest accompanied by an increase in apoptotic cell death. Together, these data indicate that PTBP1 supports spermatogenesis through regulation of cell proliferation activity in spermatogonia.

PTBPs are highly conserved RBPs among species. PTBP1 controls cellular differentiation or specification, especially during neural cell development \[[@r13], [@r26], [@r43]\]. For example, PTBP1 governs transition of neural progenitor cells to neurons by regulating AS of neuron-specific exons \[[@r13]\]. During germ cell development, loss of function of the germ cell--specific isoform of PTBP homolog dmPTB in *Drosophila* results in severe disruption of cones of the spermatid individualization complex and causes male-only infertility \[[@r21]\]. Failure of spermatogenesis caused by lack of PTBPs is also observed in the mouse. Germ cell--specific KO of *Ptbp2*, one of the PTBP orthologs in mice, shows comparable activity in spermatogonial mitosis, or entry into meiosis, where it causes loss of mature spermatozoa due to severe arrest of spermatid elongation, and results in a massive increase in multinucleated giant cell formation in seminiferous tubules \[[@r23]\]. The present study also revealed abnormal spermatogenesis caused by lack of PTBP1, although the abnormal phenotype was mainly observed in spermatogonial proliferation, not in spermatid maturation as shown in the *Ptbp2* cKO in mice. PTBP1 is strongly expressed by spermatogonia and becomes less evident in the differentiating spermatocytes or spermatids ([Fig. 1B and 1C](#fig_001){ref-type="fig"}). By contrast, PTBP2 expression is weak in spermatogonia but becomes stronger at the onset of meiosis entry, maintaining this high level until the round spermatid stage \[[@r15]\]. The different phenotypes between *Ptbp1* cKO and *Ptbp2* cKO mice may be attributed to the different spatiotemporal expression patterns of PTBP1 and PTBP2 in the testis. Another possibility is that, although *Ptbp1* and *Ptbp2* are orthologous genes, and show binding to similar exons, a certain amount of AS is regulated differentially by PTBP1 and PTBP2, as observed in neural cells \[[@r12]\]. Therefore, target RNAs of PTBP1 or PTBP2 in the testicular germ cells may be distinct, at least to some extent, and result in a different phenotype in the KO models.

Mitotically inactive gonocytes begin proliferation soon after birth and form a population of spermatogonia \[[@r1], [@r2]\]. This study showed that seminiferous tubules without germ cells became fewer according to neonatal development in the control, whereas they remained high in the *Ptbp1* cKO mice ([Fig. 3B](#fig_003){ref-type="fig"}), suggesting that proliferation might be downregulated as a result of the loss of PTBP1. Cell proliferation arrest was also observed *in vitro* ([Fig. 5D](#fig_005){ref-type="fig"}). It would note that 4OHT-administered *Ptbp1-FW* also showed retarded proliferation compared to the ethanol-administered *Ptbp1-FF* or *Ptbp1-FW*. It is unclear whether this deleterious effect was attributed to toxicity of 4OHT or heterogeneous deletion of *Ptbp1*. On the other hand, 4OHT-administerd *Ptbp1-FF* GS cells represented far severe phenotype than 4OHT-administerd *Ptbp1-FW* GS cells , suggesting that PTBP1 contributes to spermatogonial cell proliferation. In addition, a previous study \[[@r29]\] revealed that 5-bromo-2\[prime\]-deoxyuridine--incorporating activity, which represents DNA synthesis and cell proliferation, is significantly lower in *Ptbp1* null embryos. These results indicated that PTBP1 positively controls cell proliferation in many types of cells. By contrast, we could not detect any significant changes of Ki67-positive cycling cell numbers in spermatogonia *in vivo* between *Ptbp1* cKO mice and controls either during neonatal stage ([Fig. 3E and 3F](#fig_003){ref-type="fig"}). Ki67 is a common marker for cell proliferation and is able to distinguish a group of cells in G0 phase (Ki67 negative) or in G1/S/G2/M phase (Ki67 positive). By contrast, Ki67 staining does not necessarily relate to the speed of cell proliferation. Indeed, embryonic stem cells lacking PTBP1 had a slower proliferation speed than cells with PTBP1; this retarded proliferation was caused by an increase in M-phase arrest, but not of G0-phase arrest \[[@r28]\]. We also observed the similar phenomena that ratio of G2/M phase became more in the *Ptbp1-FF* GS cells after 4OHT administration. In addition, our *in vivo* study showed that the area of seminiferous tubules became smaller in the *Ptbp1* cKO mice according to age, whereas this area increased in the controls ([Fig. 4D](#fig_004){ref-type="fig"}), suggesting a lower activity of spermatogenesis in the *Ptbp1* cKO mice. Therefore, it is possible that PTBP1 controls spermatogonial cell proliferation via regulating the speed of cell division. Further study to investigate the speed of spermatogonial proliferation in the *Ptbp1* cKO mice would be useful, perhaps by using 5-bromo-2'-deoxyuridine incorporation labeling or CreERT/loxP-mediated pulse reporter labeling followed by lineage tracing.

Loss of PTBP1 in cultured GS cells causes an increase in apoptotic cell death in GS cells *in vitro* ([Fig. 5G](#fig_005){ref-type="fig"}); however, immunohistochemistry did not show a significant increase of cleaved caspase-3 (CC3)--positive cells *in vivo* either during neonatal or adult stages ([Fig. 3D](#fig_003){ref-type="fig"} and [4C](#fig_004){ref-type="fig"}). Several studies reported opposing results of PTBP1-mediated induction of apoptosis. For example, knockdown of PTBP1 in human colon cancer cell lines resulted in an increase in apoptosis \[[@r44]\]. The conventional *Ptbp1* KO mouse also showed an increase in apoptotic cell death in the fetus soon after implantation (embryonic day 7.5) \[[@r29]\]. By contrast, drug-induced apoptosis occurs more frequently in the PTBP1-high A127 cell line compared with the PTBP1-low LN18 cell line, cell lines from human glioblastoma \[[@r45]\], and knockdown of PTBP1 in the human chronic myeloid leukemia K562 cell line strengthens tolerance against drug-induced apoptosis \[[@r46]\]. Therefore, apoptotic response after *Ptbp1* manipulation might vary among types of cells or tissues.

The next step is to identify PTBP1 target RNAs and their networks to regulate homeostasis of spermatogonia. Thus, further study is needed via RNA immunoprecipitation followed by sequencing, or RNA sequencing, to clarify PTBP1 target RNA, transcriptome, or AS changes in spermatogonia for mining detailed molecular functions regulated by PTBP1.
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